First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Shares Up 0.3% – Here’s Why

Posted by Doug Wharley on Oct 22nd, 2026

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) rose 0.3% during mid-day trading on Wednesday. The stock traded as high as $274.25 and last traded at $272.46. Approximately 58,524 shares traded hands during trading, a decline of 46% from the average daily volume of 108,956 shares. The stock had previously closed at $271.77.

First Trust NYSE Arca Biotechnology Index Fund Stock Up 0.3%

The stock has a market cap of $3.00 billion, a price-to-earnings ratio of 21.72 and a beta of 0.66. The business’s 50 day simple moving average is $267.42 and its 200 day simple moving average is $241.72.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of institutional investors and hedge funds have recently modified their holdings of the company. Arwa LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the 3rd quarter worth about $415,000. Wagner Wealth Management Corp bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the 3rd quarter worth about $2,322,000. Gimbal Financial boosted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 4.5% during the 3rd quarter. Gimbal Financial now owns 3,755 shares of the company’s stock worth $1,022,000 after buying an additional 162 shares during the period. Robertson Stephens Wealth Management LLC grew its stake in First Trust NYSE Arca Biotechnology Index Fund by 2.5% in the 3rd quarter. Robertson Stephens Wealth Management LLC now owns 4,241 shares of the company’s stock valued at $1,155,000 after buying an additional 103 shares during the last quarter. Finally, McKinley Carter Wealth Services Inc. acquired a new position in First Trust NYSE Arca Biotechnology Index Fund in the 3rd quarter valued at about $1,247,000.

About First Trust NYSE Arca Biotechnology Index Fund

(Get Free Report)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.